Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients

Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients

Background: Diabetes mellitus is a chronic metabolic disorder of hyperglycemia. Chronic hyperglycemia produces advanced glycation end products such as the methylglyoxal (MGO) which interferes with cell functions, insulin signaling, and β-cell functions. The present study was conducted to determine t...

Full description

Bibliographic Details
Main Authors: Muhammad Ayoob Memon, Raisa Noor Khan, Saman Riaz, Qurat Ul Ain, Masood Ahmed, Naresh Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Berberine
diabetes mellitus
insulin resistance
metformin
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2018;volume=23;issue=1;spage=110;epage=110;aulast=Memon

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2018;volume=23;issue=1;spage=110;epage=110;aulast=Memon

Similar Items